Trial · NCT00456508
Results by group39
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 39
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 1 (n=138) | -1.04 | Standard Deviation 0.773 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 2 (n=98) | -1.06 | Standard Deviation 0.731 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 3 (n=73) | -1.07 | Standard Deviation 0.801 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 4 (n=52) | -1.15 | Standard Deviation 0.791 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 5 (n=38) | -1.16 | Standard Deviation 0.746 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 6 (n=32) | -1.07 | Standard Deviation 0.806 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 7 (n=25) | -1.24 | Standard Deviation 0.797 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 8 (n=22) | -1.31 | Standard Deviation 0.667 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 9 (n=22) | -1.20 | Standard Deviation 0.764 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 10 (n=16) | -1.27 | Standard Deviation 1.027 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 11 (n=16) | -1.22 | Standard Deviation 0.643 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 12 (n=12) | -1.36 | Standard Deviation 0.677 | scores on a scale |
| Change From Baseline in Mean Symptom Complex Severity (MSCS) Score at 4 Hrs Post Dosing | DX-88 (Ecallantide) | change in MSCS at 4 hrs episode 13 (n=12) | -1.10 | Standard Deviation 0.657 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 1 (n=140) | 69.80 | Standard Deviation 35.378 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 2 (n=98) | 70.05 | Standard Deviation 40.639 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 3 (n=73) | 63.08 | Standard Deviation 42.840 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 4 (n=52) | 62.65 | Standard Deviation 42.802 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 5 (n=39) | 65.13 | Standard Deviation 34.858 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 6 (n=32) | 60.42 | Standard Deviation 40.866 | scores on a scale |
| Treatment Outcome Score (TOS) at 4 Hrs Post Dosing, Based on the Patient Assessment of Baseline Severity of Symptoms | DX-88 (Ecallantide) | TOS at 4 hrs for episode 7 (n=25) | 56.20 | Standard Deviation 34.229 | scores on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00456508/results